# Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

> **NCT06441955** · PHASE4 · RECRUITING · sponsor: **Well- Konnect Healthcare Services and Research Firm** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19, Long Haul

## Interventions

- **DRUG:** Ritonavir-Boosted Nirmatrelvir (Paxlovid)
- **DIAGNOSTIC_TEST:** Physiological Evaluation
- **BIOLOGICAL:** Moderna COVID-19 Vaccine
- **BEHAVIORAL:** Biopsychological
- **BEHAVIORAL:** Behavioral (e.g., Psychotherapy, Lifestyle Counseling)
- **GENETIC:** Genetic (including gene transfer, stem cell and recombinant DNA)
- **COMBINATION_PRODUCT:** Multidisciplinary approach

## Key facts

- **NCT ID:** NCT06441955
- **Lead sponsor:** Well- Konnect Healthcare Services and Research Firm
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2030-09-30
- **Final completion:** 2030-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06441955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06441955, "Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06441955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*